Show simple item record

dc.contributor.authorReyland, L
dc.contributor.authorDwight, M
dc.contributor.authorBullock, T
dc.contributor.authorLatham, T
dc.contributor.authorLord, K
dc.contributor.authorWardle, A
dc.contributor.authorPalmer, D
dc.contributor.authorEggington, J
dc.contributor.authorCallaghan, T
dc.contributor.authorSeals, Deborah
dc.contributor.authorKulkarni, Samar
dc.date.accessioned2020-01-29T15:17:55Z
dc.date.available2020-01-29T15:17:55Z
dc.date.issued2020en
dc.identifier.citationReyland L, Dwight M, Bullock T, Latham T, Lord K, Wardle A, et al. Two case reports involving therapeutic monoclonal anti-CD47 (Hu5F9-G4), it's effect on compatibility testing and subsequent selection of components for transfusion. Transfus Med. 2020.en
dc.identifier.pmid31914482en
dc.identifier.doi10.1111/tme.12664en
dc.identifier.urihttp://hdl.handle.net/10541/622709
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1111/tme.12664en
dc.titleTwo case reports involving therapeutic monoclonal anti-CD47 (Hu5F9-G4), it's effect on compatibility testing and subsequent selection of components for transfusionen
dc.typeArticleen
dc.contributor.departmentNHS Blood and Transplant-Filton, Red Cell Immunohaematology Laboratory, Bristol, UKen
dc.identifier.journalTransfusion Medicineen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record